Literature DB >> 33946306

D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect.

Romina Oliva1, Abdul Rajjak Shaikh2, Andrea Petta3, Anna Vangone4, Luigi Cavallo2.   

Abstract

The crown of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is constituted by its spike (S) glycoprotein. S protein mediates the SARS-CoV-2 entry into the host cells. The "fusion core" of the heptad repeat 1 (HR1) on S plays a crucial role in the virus infectivity, as it is part of a key membrane fusion architecture. While SARS-CoV-2 was becoming a global threat, scientists have been accumulating data on the virus at an impressive pace, both in terms of genomic sequences and of three-dimensional structures. On 15 February 2021, from the SARS-CoV-2 genomic sequences in the GISAID resource, we collected 415,673 complete S protein sequences and identified all the mutations occurring in the HR1 fusion core. This is a 21-residue segment, which, in the post-fusion conformation of the protein, gives many strong interactions with the heptad repeat 2, bringing viral and cellular membranes in proximity for fusion. We investigated the frequency and structural effect of novel mutations accumulated over time in such a crucial region for the virus infectivity. Three mutations were quite frequent, occurring in over 0.1% of the total sequences. These were S929T, D936Y, and S949F, all in the N-terminal half of the HR1 fusion core segment and particularly spread in Europe and USA. The most frequent of them, D936Y, was present in 17% of sequences from Finland and 12% of sequences from Sweden. In the post-fusion conformation of the unmutated S protein, D936 is involved in an inter-monomer salt bridge with R1185. We investigated the effect of the D936Y mutation on the pre-fusion and post-fusion state of the protein by using molecular dynamics, showing how it especially affects the latter one.

Entities:  

Keywords:  COVID-19; infectivity; molecular dynamics; mutations; spike protein

Mesh:

Substances:

Year:  2021        PMID: 33946306     DOI: 10.3390/molecules26092622

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  43 in total

1.  Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures.

Authors:  T Steiner; G Koellner
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  Receptor recognition mechanisms of coronaviruses: a decade of structural studies.

Authors:  Fang Li
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

3.  Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein.

Authors:  Jean Kaoru Millet; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 4.  Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence.

Authors:  Taylor Heald-Sargent; Tom Gallagher
Journal:  Viruses       Date:  2012-04-12       Impact factor: 5.048

5.  GISAID: Global initiative on sharing all influenza data - from vision to reality.

Authors:  Yuelong Shu; John McCauley
Journal:  Euro Surveill       Date:  2017-03-30

6.  Data, disease and diplomacy: GISAID's innovative contribution to global health.

Authors:  Stefan Elbe; Gemma Buckland-Merrett
Journal:  Glob Chall       Date:  2017-01-10

Review 7.  Candidate drugs against SARS-CoV-2 and COVID-19.

Authors:  Dwight L McKee; Ariane Sternberg; Ulrike Stange; Stefan Laufer; Cord Naujokat
Journal:  Pharmacol Res       Date:  2020-04-29       Impact factor: 7.658

8.  Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.

Authors:  Yuanmei Zhu; Danwei Yu; Hongxia Yan; Huihui Chong; Yuxian He
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

9.  Structural basis of receptor recognition by SARS-CoV-2.

Authors:  Jian Shang; Gang Ye; Ke Shi; Yushun Wan; Chuming Luo; Hideki Aihara; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Nature       Date:  2020-03-30       Impact factor: 49.962

10.  Cell entry mechanisms of SARS-CoV-2.

Authors:  Jian Shang; Yushun Wan; Chuming Luo; Gang Ye; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-06       Impact factor: 11.205

View more
  5 in total

1.  In Silico Screening and Testing of FDA-Approved Small Molecules to Block SARS-CoV-2 Entry to the Host Cell by Inhibiting Spike Protein Cleavage.

Authors:  E Sila Ozdemir; Hillary H Le; Adem Yildirim; Srivathsan V Ranganathan
Journal:  Viruses       Date:  2022-05-24       Impact factor: 5.818

2.  Community-level SARS-CoV-2 sequence diversity revealed by wastewater sampling.

Authors:  Candice L Swift; Mirza Isanovic; Karlen E Correa Velez; R Sean Norman
Journal:  Sci Total Environ       Date:  2021-08-18       Impact factor: 7.963

3.  Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core.

Authors:  Chiara Marchetti; Serena Vaglietti; Francesca Rizzo; Giovanna Di Nardo; Luca Colnaghi; Mirella Ghirardi; Ferdinando Fiumara
Journal:  Virus Evol       Date:  2021-12-15

4.  Growth, Antigenicity, and Immunogenicity of SARS-CoV-2 Spike Variants Revealed by a Live rVSV-SARS-CoV-2 Virus.

Authors:  Limin S Ding; Yuhang Zhang; Dan Wen; Jianbo Ma; Hao Yuan; Hongyue Li; Shuguang Duo; Fei Yuan; Yong E Zhang; Aihua Zheng
Journal:  Front Med (Lausanne)       Date:  2022-01-07

5.  Immunoinformatics Aided Design and In-Vivo Validation of a Cross-Reactive Peptide Based Multi-Epitope Vaccine Targeting Multiple Serotypes of Dengue Virus.

Authors:  Vikas Kaushik; Sunil Krishnan G; Lovi Raj Gupta; Utkarsh Kalra; Abdul Rajjak Shaikh; Luigi Cavallo; Mohit Chawla
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.